Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

The association between neutrophil gelatinase-associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*.

Nymo SH, Ueland T, Askevold ET, Flo TH, Kjekshus J, Hulthe J, Wikstrand J, McMurray J, Van Veldhuisen DJ, Gullestad L, Aukrust P, Yndestad A.

J Intern Med. 2012 May;271(5):436-43. doi: 10.1111/j.1365-2796.2011.02503.x.

2.

Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.

Gravning J, Askevold ET, Nymo SH, Ueland T, Wikstrand J, McMurray JJ, Aukrust P, Gullestad L, Kjekshus J; CORONA Study Group..

Circ Heart Fail. 2014 Jan;7(1):96-103. doi: 10.1161/CIRCHEARTFAILURE.113.000450.

3.

Osteoprotegerin predicts progression of chronic heart failure: results from CORONA.

Ueland T, Dahl CP, Kjekshus J, Hulthe J, Böhm M, Mach F, Goudev A, Lindberg M, Wikstrand J, Aukrust P, Gullestad L.

Circ Heart Fail. 2011 Mar;4(2):145-52. doi: 10.1161/CIRCHEARTFAILURE.110.957332.

4.

The role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction.

Kirbiš S, Gorenjak M, Sinkovič A.

BMC Cardiovasc Disord. 2015 Jun 13;15:49. doi: 10.1186/s12872-015-0054-9.

5.

Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).

Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group..

J Am Coll Cardiol. 2009 Nov 10;54(20):1850-9. doi: 10.1016/j.jacc.2009.06.041.

6.

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.

Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veldhuisen DJ.

Eur J Heart Fail. 2011 Aug;13(8):846-51. doi: 10.1093/eurjhf/hfr087.

7.

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.

van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL.

Circ Heart Fail. 2014 Jan;7(1):35-42. doi: 10.1161/CIRCHEARTFAILURE.113.000242.

8.

Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.

Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C.

Acute Card Care. 2014 Sep;16(3):93-101. doi: 10.3109/17482941.2014.911915.

PMID:
24836558
9.

Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.

Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, Maisel AS.

J Am Coll Cardiol. 2012 Mar 20;59(12):1101-9. doi: 10.1016/j.jacc.2011.11.046.

10.

Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, Adourian A, Böhm M, van Veldhuisen DJ, Komajda M, Cleland JG, Wikstrand J, McMurray JJ, Aukrust P; CORONA Study Group..

Eur Heart J. 2012 Sep;33(18):2290-6.

PMID:
22513778
11.

Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.

Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL, George I, Farr MA, Mancini DM, Schulze PC.

J Heart Lung Transplant. 2014 Dec;33(12):1215-22. doi: 10.1016/j.healun.2014.06.007.

12.

The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).

Gullestad L, Ueland T, Kjekshus J, Nymo SH, Hulthe J, Muntendam P, McMurray JJ, Wikstrand J, Aukrust P.

Am Heart J. 2012 Dec;164(6):878-83. doi: 10.1016/j.ahj.2012.08.021.

PMID:
23194488
13.

Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort study.

Helanova K, Littnerova S, Kubena P, Ganovska E, Pavlusova M, Kubkova L, Jarkovsky J, Pavkova Goldbergova M, Lipkova J, Gottwaldova J, Kala P, Toman O, Dastych M, Spinar J, Parenica J.

BMJ Open. 2015 Oct 5;5(10):e006872. doi: 10.1136/bmjopen-2014-006872.

14.

Predictive value of endostatin in chronic heart failure patients with poor kidney function.

Ueland T, Aukrust P, Nymo SH, Kjekshus J, McMurray JJ, Wikstrand J, Wienhues-Thelen UH, Block D, Zaugg C, Gullestad L.

Cardiology. 2015;130(1):17-22. doi: 10.1159/000368220.

PMID:
25428583
15.

Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials.

Latini R, Gullestad L, Masson S, Nymo SH, Ueland T, Cuccovillo I, Vårdal M, Bottazzi B, Mantovani A, Lucci D, Masuda N, Sudo Y, Wikstrand J, Tognoni G, Aukrust P, Tavazzi L; Investigators of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA) and GISSI-Heart Failure (GISSI-HF) trials..

Eur J Heart Fail. 2012 Sep;14(9):992-9.

16.

Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.

Przybylowski P, Malyszko J, Malyszko JS.

Transplant Proc. 2010 Jun;42(5):1797-802. doi: 10.1016/j.transproceed.2010.02.079.

PMID:
20620526
17.

Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.

Damman K, van Veldhuisen DJ, Navis G, Voors AA, Hillege HL.

Eur J Heart Fail. 2008 Oct;10(10):997-1000. doi: 10.1016/j.ejheart.2008.07.001.

18.

Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis.

Lindberg S, Jensen JS, Mogelvang R, Pedersen SH, Galatius S, Flyvbjerg A, Magnusson NE.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2135-42. doi: 10.1161/ATVBAHA.114.303950.

19.

Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.

Abdul-Rahim AH, Perez AC, Fulton RL, Jhund PS, Latini R, Tognoni G, Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ; Investigators of the Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA).; GISSI-Heart Failure (GISSI-HF) Committees and Investigators..

Circulation. 2015 Apr 28;131(17):1486-94; discussion 1494. doi: 10.1161/CIRCULATIONAHA.114.013760.

20.

NGAL and NT-proBNP levels in diabetic patients with macroproteinuria.

Taskapan H, Taskapan MC, Orman I, Ulutas O, Yigit A, Ozyalin F, Yologlu S.

Ren Fail. 2013 Oct;35(9):1273-7. doi: 10.3109/0886022X.2013.824336.

PMID:
23964619
Items per page

Supplemental Content

Support Center